DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE: Safety Overview
| Metric | DEFIBROTIDE | DELAFLOXACIN MEGLUMINE |
|---|---|---|
| Total FAERS Reports | 3,740 | 234 |
| Deaths Reported | 1,804 | 4 |
| Death Rate | 48.2% | 1.7% |
| Hospitalizations | 832 | 17 |
| Average Patient Age | 36.3 yrs | 61.6 yrs |
| % Female Patients | 38.7% | 47.4% |
| FDA Approval Date | Mar 30, 2016 | Jun 19, 2017 |
| Manufacturer | Jazz Pharmaceuticals, Inc. | Melinta Therapeutics, LLC |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |